Angiogenesis: a harmonized target for recovery after stroke

Stroke. 2012 Aug;43(8):2270-4. doi: 10.1161/STROKEAHA.111.642710. Epub 2012 May 22.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / therapeutic use
  • Brain Ischemia / drug therapy
  • Brain Ischemia / pathology*
  • Exercise Therapy
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Neovascularization, Physiologic / drug effects
  • Neovascularization, Physiologic / physiology*
  • Nerve Growth Factors / physiology
  • Nerve Growth Factors / therapeutic use
  • Phosphodiesterase 5 Inhibitors / therapeutic use
  • Physical Therapy Modalities
  • Recovery of Function*
  • Stroke / drug therapy
  • Stroke / pathology*

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Nerve Growth Factors
  • Phosphodiesterase 5 Inhibitors